Balanced news tone
News Sentiment
ANGO sentiment intelligence
AngioDynamics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-2.3% over one week, +5.7% over four weeks, trend active, and materially above fair value.
AngioDynamics 4Q Loss/Shr 27c >ANGO
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Earnings
81/100 classification
One-week reaction
-2.3%
Price reacting lower
Trend fit
Trend active
5.7% over four weeks
Fair value
44.0%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
9
Neutral
18
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Moomoo
Direct company coverage
AngioDynamics 4Q Loss/Shr 27c >ANGO
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Jul 2026 23:36
- Source
- Moomoo
simplywall.st
Direct company coverage
AngioDynamics (ANGO) Stock Faces Profitability Question As Q4 EPS Loss Deepens Bearish Narrative
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 15 Jul 2026 22:37
- Source
- simplywall.st
TradingView
Direct company coverage
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 15 Jul 2026 14:29
- Source
- TradingView
Moomoo
Direct company coverage
Lake Street Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $24
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 14 Jul 2026 20:16
- Source
- Moomoo
Stock Titan
Direct company coverage
AngioDynamics (NASDAQ: ANGO) details device portfolio and risk factors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 20:01
- Source
- Stock Titan
GuruFocus.com
Direct company coverage
AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 Jul 2026 19:00
- Source
- GuruFocus.com
MarketBeat
Direct company coverage
AngioDynamics Q4 2026 Earnings Call Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 17:12
- Source
- MarketBeat
GuruFocus
Direct company coverage
Is AngioDynamics Inc (ANGO) Overvalued After Q4 Earnings Miss? E
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 14 Jul 2026 13:33
- Source
- GuruFocus
Investing.com
Direct company coverage
Earnings call transcript: AngioDynamics beats Q4 2026 estimates, shares rise
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 Jul 2026 13:25
- Source
- Investing.com
MarketBeat
Direct company coverage
AngioDynamics Q4 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 13:03
- Source
- MarketBeat
Seeking Alpha
Direct company coverage
AngioDynamics, Inc. 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:ANGO) 2026-07-14
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 12:31
- Source
- Seeking Alpha
MSN
Direct company coverage
AngioDynamics tops revenue forecasts and raises sales outlook for fiscal 2027 (ANGO)
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 Jul 2026 11:39
- Source
- MSN
Stock Titan
Direct company coverage
Record 2026 sales as AngioDynamics (NASDAQ: ANGO) grows Med Tech 18%
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 11:31
- Source
- Stock Titan
Market source
Direct company coverage
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 11:15
- Source
- Market source
Quiver Quantitative
Direct company coverage
ANGIODYNAMICS ($ANGO) Releases Q4 2026 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 10:30
- Source
- Quiver Quantitative
WKYC
Direct company coverage
AngioDynamics: Fiscal Q4 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 10:18
- Source
- WKYC
Business Wire
Direct company coverage
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 Jul 2026 10:00
- Source
- Business Wire
TradingView
Direct company coverage
Price to earnings forward of AngioDynamics, Inc. – NASDAQ:ANGO
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Jul 2026 14:18
- Source
- TradingView
Business Wire
Direct company coverage
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Jun 2026 12:00
- Source
- Business Wire
Stock Titan
Direct company coverage
AngioDynamics sets July 14 call for fiscal 2026 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Zacks Investment Research
Direct company coverage
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Zacks Investment Research
MT Newswires
Direct company coverage
AngioDynamics Secures FDA Approval to Begin Benign Prostatic Hyperplasia Study
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 17 Jun 2026 12:52
- Source
- MT Newswires
scanx.trade
Direct company coverage
AngioDynamics gains FDA IDE approval for RELIEF study of NanoKnife System
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 17 Jun 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
AngioDynamics (ANGO) Margins Stay Negative In Q2 2026 And Test Bullish Turnaround Hopes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2026 07:00
- Source
- simplywall.st
Quiver Quantitative
Direct company coverage
ANGIODYNAMICS ($ANGO) Releases Q3 2026 Earnings | ANGO Stock News
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Quiver Quantitative
Market source
Direct company coverage
AngioDynamics (ANGO) Reports Q3 Loss, Tops Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
AngioDynamics schedules April 2 earnings call before market open
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Mar 2026 07:00
- Source
- Stock Titan
Gotrade
Direct company coverage
AngioDynamics Inc (ANGO) Stock Price Today & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jan 2026 02:24
- Source
- Gotrade
simplywall.st
Direct company coverage
Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum
- Tone
- Positive 68/100
- Event
- Guidance
- Published
- 09 Jan 2026 08:00
- Source
- simplywall.st
The Motley Fool
Direct company coverage
Why AngioDynamics Stock Is Sinking Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jan 2026 08:00
- Source
- The Motley Fool